Alec Szlachta-McGinn

Dr. Alec Szlachta-McGinn

UCLA Medical Center
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2014 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
KPKyung Soo Park
Kyung Soo Park
IBIan Bayles
Ian Bayles
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
JPJoshua Paul
Joshua Paul
JBJulie Boiko
Julie Boiko
Christine MilcarekChristine Milcarek
Christine Milcarek
Differentiation of B cells into Ab-secreting cells induces changes in gene transcription, IgH RNA processing, the unfolded protein response (UPR), and cell architecture. The transcription elongation factor eleven nineteen lysine-rich leukemia gene (ELL2) stimulates the processing of the secreted form of the IgH mRNA from the H chain gene. Mice (mus musculus) with the ELL2 gene floxed in either exon 1 or exon 3 were constructed and crossed to CD19-driven cre/CD19+. The B cell–specific ELL2 conditional knockouts (cKOs; ell2loxp/loxp CD19cre/+) exhibit curtailed humoral responses both in 4-hydroxy-3-nitrophenyl acetyl–Ficoll and in 4-hydroxy-3-nitrophenyl acetyl–keyhole limpet hemocyanin immunized animals; recall responses were also diminished. The number of immature and recirculating B cells in the bone marrow is increased in the cKOs, whereas plasma cells in spleen are reduced relative to control animals. There are fewer IgG1 Ab-producing cells in the bone marrow of cKOs. LPS ex vivo–stimulated B220loCD138+ cells from ELL2-deficient mouse spleens are 4-fold less abundant than from control splenic B cells; have a paucity of secreted IgH; and have distended, abnormal-appearing endoplasmic reticulum. IRE1α is efficiently phosphorylated, but the amounts of Ig κ, ATF6, BiP, Cyclin B2, OcaB (BOB1, Pou2af1), and XBP1 mRNAs, unspliced and spliced, are severely reduced in ELL2-deficient cells. ELL2 enhances the expression of BCMA (also known as Tnfrsf17), which is important for long-term survival. Transcription yields from the cyclin B2 and the canonical UPR promoter elements are upregulated by ELL2 cDNA. Thus, ELL2 is important for many aspects of Ab secretion, XBP1 expression, and the UPR.

31 January 2020 in BMC Pregnancy and Childbirth
Verified
Journal Article
Open access
PDF file
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
JMJenny Mei
Jenny Mei
KTKhalil Tabsh
Khalil Tabsh
YAYalda Afshar
Yalda Afshar
Background: To investigate differences in perioperative outcomes by type of skin incision, transverse versus vertical, for planned cesarean hysterectomy for placenta accreta spectrum (PAS). Methods: A retrospective cohort study of all women who underwent a planned cesarean hysterectomy for abnormal placentation at a single academic medical center over 5 years. The Student’s t-test was used for continuous variables and Fisher’s exact test compared categorical variables. Continuous data were presented as median and compared using the Wilcoxon-rank sum test. Results: Forty-two planned cesarean hysterectomies were identified. A transverse skin incision was made in 43% (n = 18); a vertical skin incision was made in 57% (n = 24). Skin incision was independent of BMI (30.3 vs 30.8 kg/m2, p = 0.37), placental location (p = 0.82), and PAS-subtype (p = 0.26). Mean estimated blood loss (EBL) was 2.73 l (L) (range 0.5–20) and was not significantly different between transverse and vertical skin incision (2.6 L vs 2.8 L, p = 0.8). There was significantly shorter operative time with transverse skin incision (180 vs 238 min, p = 0.03), with no difference in intraoperative complications, including cystotomy (p = 0.22) and ureteral injury (p = 0.73). Postoperatively, there was no difference in maternal length of stay (4.8 vs 4.4 days, p = 0.74) or post-operative opioid use (117 vs 180 morphine equivalents, p = 0.31). Conclusion: Transverse skin incision is associated with shorter operative time for patients undergoing planned cesarean hysterectomy. There was no difference in EBL, intraoperative complications, postoperative length of stay, or opioid use. Given an increasing rate of cesarean hysterectomy, we should consider variables that optimize maternal outcomes and resource utilization.

1 January 2016 in Journal of Lower Genital Tract Disease
Verified
Journal Article
Closed access
SBStephanie A. Blankenship
Stephanie A. Blankenship
PDPriyanka Debnath
Priyanka Debnath
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
KMKarla Maguire
Karla Maguire
JGJorge J. Garcia
Jorge J. Garcia
JPJoNell E. Potter
JoNell E. Potter
Medical providers have initiated anal cytology screening among women to detect anal neoplasia early. Lack of knowledge of the human papillomavirus (HPV) and anticipated screening discomfort may limit patient acceptance. This study investigates attitudes toward anal cytology screening among women. Women seen for gynecologic care at an urban university medical center were invited to complete an anonymous survey assessing their understanding of HPV and interest in anal cytology screening. Subjects reported the level of pain, discomfort, and embarrassment they expected from screening on a 100-mm visual analog scale. Four hundred four women with mean (SD) age 36 (13) years met criteria for participation. Three hundred thirty-five women reported their race: 52% were white and 36% were African American. Three hundred forty-eight women reported their ethnicities: 76% were Hispanic and 12% were Haitian. Twenty-two percent had never heard of HPV, 57% were not familiar with anal cytology screening, 67% acknowledged that screening was very helpful in detecting anal neoplasia early, and 28% were very interested in undergoing screening. Mean (SD) level of anticipated pain, discomfort, and embarrassment during screening was 62 (32), 68 (30), and 58 (34) mm, respectively. Level of familiarity with anal cytology screening (p < .001), belief in its utility in detecting anal neoplasia (p < .001), and level of anticipated pain (p = .004) were significant predictors of acceptability. Medical providers should improve counseling about anal cytology screening among at-risk women to familiarize them with the procedure, describe its role in detecting anal neoplasia, and address expectations surrounding pain to increase its acceptability.

7 May 2020 in Infectious Diseases in Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
AAAlexandra Aserlind
Alexandra Aserlind
Lunthita DuthelyLunthita Duthely
Lunthita Duthely
SOSean Elliot Oldak
Sean Elliot Oldak
RBRuchi Babriwala
Ruchi Babriwala
JPJoNell Potter
JoNell Potter
Background. The CDC and ACOG have issued guidelines for HIV screening in pregnancy for patients living in areas with high prevalence of HIV in order to minimize perinatal vertical transmission. There is a lack of data examining providers’ compliance with these guidelines in at-risk patient populations in the United States. Objective. To evaluate if HIV screening in pregnant women was performed according to guidelines at a large, urban, tertiary care medical center in South Florida. Study Design. A retrospective review was performed on 1270 prenatal and intrapartum records from women who delivered a live infant in 2015 at a single institution. Demographic and outcome data were chart abstracted and analyzed using arithmetic means and standard deviations. Results. Of the 1270 patients who met inclusion criteria, 1090 patients initiated prenatal care in the first or second trimester and delivered in the third trimester. 1000 (91.7%) patients were screened in the first or second trimester; however, only 822 (82.2%) of these were retested in the third trimester during prenatal care. Among the 178 patients lacking a third trimester test, 159 (89.3%) received rapid HIV testing upon admission for delivery. Of the 1090 patients who initiated prenatal care in the first or second trimester and delivered in the third trimester, 982 (90.1%) were screened in accordance with recommended guidelines. Of the 1270 patients initiating care in any trimester, 24 (1.9%) had no documented prenatal HIV test during prenatal care, however 22 (91.7%) had a rapid HIV test on admission for delivery. Two (0.16%) patients were not tested prenatally or prior to delivery. Conclusion. Despite 99.8% of women having at least one HIV screening test during pregnancy, there is room for improvement in routine prenatal screening in both early pregnancy and third trimester prior to onset of labor in this high-risk population.

21 October 2021 in Current Oncology
Verified
Journal Article
Open access
PDF file
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
BCBartosz Chmielowski
Bartosz Chmielowski
YKYuna Kang
Yuna Kang
SRSteven Raman
Steven Raman
SMSanaz Memarzadeh
Sanaz Memarzadeh
Primary mucosal melanomas of the female genital tract account for one percent or less of all cases of melanoma with even fewer originating in the clitoris. Given the rarity of diagnosis of clitoral melanoma, there is a paucity of data guiding management. There is no supporting evidence that radical vulvectomy (with or without inguinal lymphadenopathy) is associated with improved disease-free or overall survival compared to partial vulvectomy or wide local excision. Additionally, there is no data to evaluate the role of sentinel lymph node biopsy or extensive lymphadenectomy in clitoral melanoma, however previous evidence demonstrates the utility of regional lymph node sampling in predicting survival in women with female genital tract mucosal melanoma. Adjuvant therapy considerations are often extrapolated from their use in treating cutaneous melanomas, including immune checkpoint inhibitors and other immunotherapy agents. Adjuvant radiation therapy has limited utility except in cases of bulky, unresectable disease, or when inguinal lymph nodes are positive for metastasis. The 52 year-old patient presented in this review was diagnosed with locally invasive advanced stage clitoral melanoma presenting as an exophytic clitoral mass. She underwent diagnostic primary tumor resection, which demonstrated ulcerative melanoma with spindle cell features extending to a Breslow depth of at least 28 mm. She subsequently underwent secondary wide local excision with groin sentinel lymph node biopsy, and adjuvant treatment with pembrolizumab. This article also emphasizes the importance of a multidisciplinary team involving gynecologic oncology, medical oncology, radiology, and pathology for management of this rare type of primary mucosal melanoma of the female genital tract.

13 August 2026 in Clinical Infectious Diseases
Verified
Journal Article
Open access
ASAlec Szlachta-McGinn
Alec Szlachta-McGinn
JAJames E Ackerman
James E Ackerman
CCCrystal Cisneros
Crystal Cisneros
LHL Marcella Henao
L Marcella Henao
ASAnn Stapleton
Ann Stapleton
AAA. Lenore Ackerman
A. Lenore Ackerman
Background: Quantitative polymerase chain reaction (qPCR) has high sensitivity in detecting uropathogens. While qPCR is increasingly used in urinary tract infection (UTI) diagnosis, its accuracy distinguishing UTI from noninfectious lower urinary tract symptoms (LUTS) is unclear. This study sought to assess qPCR utility in distinguishing UTI from noninfectious LUTS and controls. Methods: Quantitative polymerase chain reaction examined urinary DNA from 502 women with UTI (UTI, n = 104), noninfectious LUTS (n = 354), or controls (n = 44) for uropathogens (Escherichia coli, Klebsiella pneumoniae, Enterococcus), Lactobacilli, bacterial vaginosis-associated bacteria (Gardnerella, Prevotella, Burkholderia), and Candida albicans. Relative bacterial DNA quantities were compared across groups and menopausal strata by logistic regression. Receiver operating characteristic analysis of continuous qPCR values assessed the ability of individual and combined microbial species to distinguish UTI from LUTS and controls, with AUC ≥ 0.7 as the discrimination threshold. Results: Almost all women had detectable urinary E. coli (97.3%), Enterococcus (99.2%), K. pneumoniae (73.4%), and C. albicans (94.2%) DNA. No qPCR detection threshold could distinguish symptomatic UTI subjects from controls or noninfectious LUTS. Decreased Lactobacillus crispatus, Lactobacillus iners, and Burkholderia were seen in UTI subjects. Postmenopausal women had higher E. coli (P = .023) and Enterococcus (P = .002) levels and lower Lactobacillus (P < .001) than premenopausal women. In premenopausal women, vaginal species alone and in combination with uropathogens modestly discriminated UTI from LUTS (AUC > 0.7), although no model achieved discrimination in postmenopausal women. Conclusions: Women with UTI, noninfectious LUTS, and controls exhibit similar uropathogen levels by qPCR. Providers should exercise caution using qPCR-based tests in women without a high suspicion for UTI.